IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma

E-ISSN： 1099-1069|36|1|196-201

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 196-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the IL-6 Pathway in Multiple Myeloma and its Implications in Cancer-Associated Gene Hypermethylation

Medicinal Chemistry, Vol. 7, Iss. 5, 2011-09 ,pp. : 473-479

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting IL-17 and IL-23 in Immune Mediated Renal Disease

Current Medicinal Chemistry, Vol. 22, Iss. 38, 2015-12 ,pp. : 4341-4365

Bentham Science Publishers

Access to resources Recommend Favorite

The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3656-3660

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-18 and IL18 −607A/C and −137G/C Gene Polymorphisms in Patients with Penicillin Allergy

By Ming L Wen Q Qiao H-L Dong Z-M

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 388-398

Field House Publishing

Access to resources Recommend Favorite